BCR-ABL1 kinase domain mutation screening using next generation sequencing in CML and Ph plus ALL patients - Kizilors, A; Jackson, S; Anwar, J; Sa, I; Ficinski, L; Mian, S; Best, S; Copland, M; Hassan, S; Mead, A; Ewing, J; Drummond, M; et al. (Wiley, 2019)